COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20200117046164N2


Column Value
Trial registration number IRCT20200117046164N2
Full text link
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Mohsen Tafaghodi

Contact
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

ramreaserch@mums.ac.ir

Registration date
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-09-24

Recruitment status
Last imported at : Feb. 20, 2022, 5:42 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Prevention

Inclusion criteria
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Asthmatic children

Exclusion criteria
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Positive history of COVID-19 Autoimmunity Malignancy Complication after nasal spray use Unwilling to continue participation in trial

Number of arms
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

research and technology office of Mashhad university of medical sciences

Inclusion age min
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

6

Inclusion age max
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Countries
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Healthy volunteers

Severity scale
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

N/A

Total sample size
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

90

primary outcome
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Investigation of preventive effect of probiotic nasal spray in incidence of upper respiratory infection Axillary temperature above 38 Celsius degree Exacerbation of Respiratory symptoms Development of gasterointestinal symptoms Abnormality in smell or gestatory senses

Notes
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 3

Arms
Last imported at : Sept. 24, 2021, 3 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 1929, "treatment_name": "Probiotic nasal spray", "treatment_type": "Nasal spray", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]